Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06148623 · ClinicalTrials.gov registry record · NA

Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation

A NA study of Healthy, sponsored by Masimo Corporation.

Completed
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT06148623 is a NA study of Healthy that has completed, run by Masimo Corporation. The registered enrollment target is 70 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06148623, a NA study of Healthy, has completed, sponsored by Masimo Corporation.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

Validate the performance of Philips FAST SpO2 with Masimo Pulse Oximetry Sensors in determining functional arterial oxygen saturation (SpO2) using arterial saturation (SaO2) as a reference in the range of 70-100% in subjects of varying skin pigmentation.

Conditions Studied

Interventions

  • DEVICE Philips FAST SpO2 with Masimo Pulse Oximetry Sensors

Study Locations (1)

California

  • Masimo Corporation - Irvine

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2023-11-13
Est. Completion 2025-01-14
Phase NA

Sponsor

Masimo Corporation

96 total trials

What the Registry Record Tells You About NCT06148623

The ClinicalTrials.gov registry entry for NCT06148623 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (89% lower). The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Philips FAST SpO2 with Masimo Pulse Oximetry Sensors is the first listed.

NCT06148623 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06148623 about?

NCT06148623 is a clinical study titled "Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation". Validate the performance of Philips FAST SpO2 with Masimo Pulse Oximetry Sensors in determining functional arterial oxygen saturation (SpO2) using arterial saturation (SaO2) as a reference in the range of 70-100% in subjects of varying skin pigmentation.

What is the current status of trial NCT06148623?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2023-11-13. Estimated completion is 2025-01-14.

What conditions does trial NCT06148623 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT06148623?

The interventions under investigation include: Philips FAST SpO2 with Masimo Pulse Oximetry Sensors (DEVICE).

Who is sponsoring clinical trial NCT06148623?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06148623 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.